Published online Sep 14, 2023. doi: 10.3748/wjg.v29.i34.5082
Peer-review started: April 19, 2023
First decision: May 27, 2023
Revised: June 9, 2023
Accepted: August 18, 2023
Article in press: August 18, 2023
Published online: September 14, 2023
Processing time: 142 Days and 5 Hours
Neuroendocrine tumors (NET) are rare heterogeneous tumors that arise from neuroendocrine cells throughout the body. Acromegaly, a rare and slowly progressive disorder, usually results from a growth hormone (GH)-secreting pituitary adenoma.
We herein describe a 38-year-old patient who was initially diagnosed with diabetes. During colonoscopy, two bulges were identified and subsequently removed through endoscopic submucosal dissection. Following the surgical intervention, the excised tissue samples were examined and confirmed to be grade 2 NET. 18F-ALF-NOTATATE positron emission tomography-computed tomography (PET/CT) and 68Ga-DOTANOC PET/CT revealed metastases in the peri-intestinal lymph nodes, prompting laparoscopic low anterior resection with total mesorectal excision. The patient later returned to the hospital because of hyperglycemia and was found to have facial changes, namely a larger nose, thicker lips, and mandibular prognathism. Laboratory tests and magnetic resonance imaging (MRI) suggested a GH-secreting pituitary adenoma. The pituitary adenoma shrunk after treatment with octreotide and was neuroendoscopically resected via a trans-sphenoidal approach. Whole-exome sequencing analysis revealed no genetic abnormalities. The patient recovered well with no evidence of recurrence during follow-up.
18F-ALF-NOTATE PET/CT and MRI with pathological analysis can effectively diagnose rare cases of pituitary adenomas complicated with rectal NET.
Core Tip: We herein present a rare case of rectal dual-source grade 2 neuroendocrine tumors with a pituitary growth hormone-secreting tumor that caused acromegaly and diabetes. The rarity of this combination makes an accurate diagnosis difficult to achieve. The correct diagnosis can be obtained by using 18F-ALF-NOTATATE-positron emission tomography–computed tomography and magnetic resonance imaging combined with pathological analysis.